We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Proteomic Markers Predicting Progression from Impaired Fasting Glucose to Diabetes: Insights from the ARIC Study

MedXY Editorial Team•Jun 27, 2026•Diabetes & Endocrinology
diabetes progressionimpaired fasting glucoseproteomicsRisk Prediction

Highlight

– Six plasma proteins were identified as significantly associated with progression from impaired fasting glucose (IFG) to diabetes within 3 years.
– Key proteins included adiponectin and receptor-type tyrosine-protein phosphatase S, implicating altered carbohydrate metabolism and glycolysis pathways.
– Incorporation of these protein markers improved diabetes risk prediction models beyond traditional clinical and demographic factors.
– Two proteins were externally validated in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort, enhancing generalizability.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Proteomic and Metabolomic Insights into Cardiac Remodeling in Breast Cancer Patients Undergoing Cardiotoxic TherapyThis study identifies novel proteomic and metabolomic biomarkers linked to cardiac dysfunction and remodeling in breast cancer patients treated with cardiotoxic therapies, revealing potential pathways for early detection and intervention.Sep 19, 2026Molecular Subtypes in Transthyretin Cardiac Amyloidosis: Insights from Proteomics Profiling and Tafamidis EfficacyComprehensive plasma proteomics reveal three molecular subtypes of transthyretin cardiac amyloidosis linked to distinct prognoses and differential tafamidis treatment responses, highlighting personalized therapeutic opportunities.Sep 13, 2026Advancing Fetal Death Detection: Identification of Novel Maternal Plasma Biomarkers Through Large-Scale Proteomic ProfilingLarge-scale proteomic analysis identifies novel maternal plasma protein biomarkers that improve detection of fetal death beyond established markers, highlighting both shared and unique pathological pathways with preeclampsia.Sep 12, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model
The LIFE-Preserved model accurately predicts short-term and lifetime risks of heart failure hospitalization or cardiovascular death in HFpEF patients, enabling tailored clinical risk stratification and improved management.
Sep 11, 2026
Predicting Hypothyroidism After Hemithyroidectomy: Development and Validation of a Clinical Nomogram for Personalized Risk AssessmentA validated nomogram predicts hypothyroidism risk within 12 months after hemithyroidectomy using clinical and pathological variables, aiding tailored patient counseling and postoperative monitoring.Sep 5, 2026
Harnessing Artificial Intelligence for Early Detection of Ovarian Cancer: Development and Validation of a Predictive Risk ModelA novel AI-driven risk prediction model for ovarian cancer demonstrates high accuracy and potential to improve early detection in screening settings.Aug 31, 2026